Navigation Links
Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element™ Platinum Chromium Stent
Date:11/11/2011

at may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; clinical trial results; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.CONTACT:

Erik Kopp508-650-8660 (office)Media RelationsBoston Scientific Corporationerik.kopp@bsci.comDavid Knutson (attending TCT)651-260-8288 (mobile)Media Relations Boston Scientific Corporationdavid.knutson@bsci.comSean Wirtjes508-652-5305 (office)Investor RelationsBoston Scientific Corporationinvestor_relations@bsci.com
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and ... consumers, employers and government health plans $23.3 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  BD Life ... Company) (NYSE: BDX ), a leading ... innovative company focused on enabling high-resolution biology, today ... unique solutions for highly multiplexed cell isolation and ... are promoting BD,s powerful BD FACS™ single-cell sorting ...
(Date:2/26/2015)... 2015  Lyric Pharmaceuticals Inc. today announced the initial ... million. The financing, co-led by RiverVest Venture Partners, Sante ... Venture Partners. Lyric is a clinical-stage ... , M.D., M.B.A., President & Chief Executive Officer and ... In 2014, Lyric closed a seed financing round of ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... to respond to agency during first quarterKENILWORTH, N.J., Jan. ... today announced that the U.S. Food and Drug Administration ... (asenapine) sublingual tablets in the acute treatment of schizophrenia ... or mixed episodes associated with bipolar I disorder in ...
... Clinical Trial for the Treatment of Pediatric Eosinophilic Esophagitis ... Cephalon, Inc . (Nasdaq: CEPH ) ... today announced that the companies have signed an agreement ... capital stock of Ception. Under the terms of ...
Cached Medicine Technology:U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 2Cephalon Signs Option Agreement to Acquire Ception Therapeutics 3Cephalon Signs Option Agreement to Acquire Ception Therapeutics 4
(Date:2/27/2015)... The Radiology Business Management Association ... class of Fellows — one of the most highly ... , Since 2009, the RBMA Fellowship program has ... members to the Association and the profession. Fellow of ... Fellow candidate must meet a very high standard for ...
(Date:2/27/2015)... 27, 2015 With Spring’s wet weather on ... condition of their crawl spaces in mind. The latest ... most common FAQs regarding crawl space conditions and repairs. ... to owners that are confused as to how water is ... of the most common ways is through cracks in the ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Is it reasonable ... youth football practices and games, and possible to do so ... other youth sports might be at high risk for concern ... some of the issues being addressed by two introductory bills, ... of a hearing last month in New York City. ...
(Date:2/27/2015)... 2015 Prescription Drug “Take-Back” events ... Enforcement Agency (DEA). Today, local law ... utilize the “Take-Back” guidelines for the proper disposal ... Eufaula Prescription Drug Disposal Event , The McInstosh ... Eufaula, Oklahoma as the “Take-Back” site for the ...
(Date:2/27/2015)... If there is one thing that drives parents into ... outbreak at their child’s school. While head lice are not ... short of a nightmare for many parents as they see ... within their child’s classroom. Just when they think the problem ... , Local lice removal company, Lice Troopers , reports ...
Breaking Medicine News(10 mins):Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Crawl Space FAQs are Answered in Clean Crawls Latest Article 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 2Health News:NYSATA Athletic Trainers Provide Expert Testimony at NYC Youth Concussion and Sports Safety Hearing 3Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:Anxiety over head lice among Miami parents as surge in head lice cases reported by local lice removal company Lice Troopers 2
... the newly incorporated subsidiary of Genomatix Software GmbH, has announced ... with the NCI/NIH for the fourth consecutive year. This years ... renewal was executed entirely between the US company and the ... pleased with our progress in putting the US company on ...
... by Rice University Psychology Professor Tony Ro has published ... known as synesthesia, in which stimulation of one sensory ... sensory pathway. , Ro,s paper, Feeling Sounds After a ... Neurology, the official journal of the American Neurological Association. ...
... the Centre for Addiction and Mental Health (CAMH) have ... of head and neck cancers, showing that people who ... , According to CAMH Principal Investigator Dr. Jrgen Rehm, ... and an increased risk for cancer of the esophagus, ...
... Projects, REDWOOD CITY, Calif., Sept. 26 ... that it has obtained,commitments from several institutional investors ... stock and warrants to purchase,approximately 2.6 million shares ... $23.7 million. The investors have agreed to purchase ...
... this valuable form of care, experts say , ... care have issued new "performance measures" meant to boost ... too many heart attack patients aren,t getting the benefit ... will also set standards of excellence for these programs ...
... Neb., Sept. 26 The close of summer traditionally,marks ... the advent of fall,and holiday baking seasons. This year, ... obesity -- healthier cooking is a growing,trend. A study ... the biggest gains in kids, body mass index occur ...
Cached Medicine News:Health News:Research at Rice may help explain aspects of synesthesia 2Health News:Research at Rice may help explain aspects of synesthesia 3Health News:Alcohol and cancer: is drinking the new smoking? 2Health News:Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing 2Health News:Heart Attack Survivors Benefit From Rehab 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 2Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 3Health News:Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R) 4
... liquid handling capability allows you to ... 5 nanoliters. Precision robotics and flexible ... so youll hit your target every ... without an air gap, providing increased ...
... System Genesis NPS based on the well-known ... to miniaturize your assays for high throughput ... direct dilutions., Furthermore it is an ... gene expression analysis, gene mapping, SNP detection ...
... Automatic dispenser for low volumes. Dispenses volumes ... -well format. Fast throughput of less than ... The dispenser features an intuitive user interface ... used to dispense liquids and suspensions, beads, ...
... dispensing of reagents, buffers and solvents for ... through eight nozzle manifolds for fast throughput. ... dispensing one, two or four reagents into ... from 200 nL to 2.0 mL with ...
Medicine Products: